S\xf8ren Smed \xd8stergaard is Vice President of Digital Health globally for Novo Nordisk (https://www.novonordisk.com/), where he leads the company\u2019s initiatives in Digital Health as well as leading the Digital Health solutions in development. Furthermore, S\xf8ren is responsible the commercial development all digital health injection & other devices in development, as well as Novo\u2019s partner strategy, data integration and commercial development strategies with their partners. S\xf8ren is a thought leader within the field. During his more than 16 years in Novo Nordisk, S\xf8ren has been able to unite and excite people towards how Digital Health can add value to pharma, the health care system and people's lives, and is passionate about the interplay between pharmaceuticals and technology and how this can be used to improve people's lives. Before this current role, S\xf8ren was the Executive Advisor to the EVP of Commercial Strategy & Corporate Affairs and ran the EVP Office for more than 2\xbd years. Prior to that he worked in various positions, mostly within Global Marketing centered around product management of medical devices and needles, as well as portfolio management. S\xf8ren also managed and developed two iterations of the Novo Nordisk launch framework, has led global launch preparations for 20+ launches, has done portfolio analysis and valuation for development assets, and has sat on global project teams leading the commercial development work for drug and device assets. S\xf8ren has a Master of Science, in Management of Innovation and Business Development, and a Bachelor of Science, in Computer Science and Business Administration, from Copenhagen Business School.\xa0
Support the show